Carlyle quarterly earnings jump 35 percent on higher fees
February 6, 2019
German ministers meet as U.S. urges Huawei exclusion: sources
February 6, 2019

Eli Lilly cuts 2019 forecast on trial failure, Loxo deal

Eli Lilly and Co cut its 2019 profit forecast on Wednesday, hit by a recent trial failure of conditionally approved cancer treatment Lartruvo and costs related to its pending acquisition of Loxo Oncology.

Powered by WPeMatico